Evidence map›Paper›PMID 37697348›Full record

ArticleBMC research notes2023

Correlation of SARS-CoV-2 RNA and nucleocapsid concentrations in samples used in INSTAND external quality assessment schemes.

Esmeralda Valiente, Samreen Falak, Andreas Kummrow, Martin Kammel, Victor M Corman, Rainer Macdonald, Heinz Zeichhardt

Abstract read
In one paragraph

Article in BMC research notes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esmeralda ValientePhysikalisch-Technische Bundesanstalt, Department 8.3 - Biomedical Optics Abbestr. 2-12, D-10587, Berlin, Germany. esmeralda.valiente@ptb.de.
Samreen FalakPhysikalisch-Technische Bundesanstalt, Department 8.3 - Biomedical Optics Abbestr. 2-12, D-10587, Berlin, Germany.
Andreas KummrowPhysikalisch-Technische Bundesanstalt, Department 8.3 - Biomedical Optics Abbestr. 2-12, D-10587, Berlin, Germany.
Martin KammelINSTAND e.V, Society for Promoting Quality Assurance in Medical Laboratories, Duesseldorf, North Rhine-Westphalia, Germany.
Victor M CormanInstitute of Virology, Charité - Universitaetsmedizin Berlin, National Consultant Laboratory for Coronaviruses, German Centre for Infection Research, Berlin, Germany.
Rainer MacdonaldPhysikalisch-Technische Bundesanstalt, Department 8.3 - Biomedical Optics Abbestr. 2-12, D-10587, Berlin, Germany.
Heinz ZeichhardtINSTAND e.V, Society for Promoting Quality Assurance in Medical Laboratories, Duesseldorf, North Rhine-Westphalia, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn routine clinical laboratories, severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is determined by reverse-transcription PCR (RT-PCR). In the COVID pandemic, a wide range of antigen detection tests were also in high demand. We investigated the correlation between SARS-CoV-2 NCap antigen and N gene concentration by analyzing samples from several INSTAND external quality assessment (EQA) schemes starting in March 2021. The absolute N gene concentration was measured using reverse transcriptase digital PCR (RT-dPCR) as reference value. Moreover, the performance of five commercial ELISA tests using an EQA inactivated SARS-CoV-2 sample at different concentrations was assessed on the basis of these reference values.

resultsQuantitative ELISA and RT-dPCR results showed a good correlation between SARS-CoV-2 NCap antigen and RNA concentration, but this correlation varies among SARS-CoV-2 isolates. A direct correlation between SARS-CoV-2 NCap antigen concentration and genome concentration should not be generally assumed.

conclusionFurther correlation studies between SARS-CoV-2 RNA and NCap antigen concentrations are needed, particularly in clinical samples and for emerging SARS-CoV-2 variants, to support the monitoring and improvement of antigen testing.

Indexed as

COVID-19RNA, ViralHumansNucleocapsidSARS-CoV-2RNA, ViralELISANucleocapsid (NCap) antigenQuantificationRNART-dPCRSARS-CoV-2

Identifiers

PMID37697348
PMCPMC10496272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.